Author

F. Raffi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Organism:virus· 1

Frequent Co-Authors

A.-G. Marcelin· 2 shared B. Vanhove· 2 shared C. Ciron· 2 shared E. Lheriteau· 2 shared E. Mevel· 2 shared G. Evanno· 2 shared O. Duvaux· 2 shared P.-J. Royer· 2 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A.-G. Marcelin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cytokine profiles in adults with imported malaria: insights from the PALUREA cohort study

C. de Roquetaillade, C. Laouenan, J.-P. Mira, C. Roy, M. Thuong, E. Azoulay, D. Gruson, F. Jacobs, J. Chommeloux, F. Raffi, L. Hocqueloux, P. Imbert, V. Jeantils, J.-L. Delassus, S. Matheron, , F. Bruneel

This study analyzes cytokine profiles in adults with imported Plasmodium falciparum malaria, finding that IL-10 and MIF are associated with disease severity and nosocomial infections.

bioRxiv · Nov 23, 2022 · PreprintImmunology

Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)

B. Vanhove, S. S. Marot, G. Evanno, I. Mallet, G. Rouvray, F. Shneiker, E. Mevel, C. Ciron, J. Rousse, P.-J. Royer, E. Lheriteau, F. Raffi, O. Duvaux, A.-G. Marcelin, V. Calvez

bioRxiv · Jan 26, 2022 · PreprintImmunology

XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 Spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants.

B. Vanhove, S. S. Marot, R. So, B. Gaborit, G. Evanno, I. Malet, G. Lafrogne, E. Mevel, C. Ciron, P.-J. Royer, E. Lheriteau, F. Raffi, R. Bruzzone, C. K. P. Mok, O. Duvaux, , V. Calvez

XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 Spike RBD, neutralizes multiple variants by targeting multiple epitopes and shows potential in clinical trials.

bioRxiv · Apr 2, 2021Immunology